Literature DB >> 8390035

A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.

M C Daly1, R H Xiang, D Buchhagen, C H Hensel, D K Garcia, A M Killary, J D Minna, S L Naylor.   

Abstract

Small cell lung cancer (SCLC) tumors frequently display deletions on the short arm of chromosome 3 suggesting the existence of a 'tumor suppressor' gene within that region whose functional inactivation may be involved in tumorigenesis. Recently, a hybrid, HA(3)BB9F, was identified that contains a small fragment of human chromosome 3 of approximately 2 Mb on a mouse (A9) background (Killary et. al., 1992). This hybrid was utilized to define a functional tumor suppressor gene within 3p22-p21 which could suppress the tumorigenic properties of the mouse fibrosarcoma cell line. The existence of a tumor suppressor gene in the region 3p22-p21 is supported by the present report which describes the assessment of 89 SCLC and 32 non-SCLC lung cancer tumors and cell lines for the existence of a homozygous deletion(s) at 43 loci on the short arm of chromosome 3. One of the SCLC cell lines was found to harbor a homozygous deletion involving the loss of five markers on chromosome 3p. All five of the markers map to the region 3p21.3-p21.2 and four of the five markers are located within the chromosome 3 fragment exhibiting properties of tumor suppression in the HA(3)BB9F hybrid. The other tumors analysed all retained at least one copy of each of the markers assessed.

Entities:  

Mesh:

Year:  1993        PMID: 8390035

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Tumor suppressors on 3p: a neoclassic quartet.

Authors:  K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration.

Authors:  E Brambilla; B Constantin; H Drabkin; J Roche
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

Authors:  A Maitra; I I Wistuba; C Washington; A K Virmani; R Ashfaq; S Milchgrub; A F Gazdar; J D Minna
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Characterization of the human beta-catenin gene.

Authors:  A L Norris; A Bailey; J Askham; A Whitehouse; P M Clissold; A F Markham; D M Meredith
Journal:  Mamm Genome       Date:  1996-02       Impact factor: 2.957

5.  Computerized polymorphic marker identification: experimental validation and a predicted human polymorphism catalog.

Authors:  J W Fondon; G M Mele; R I Brezinschek; D Cummings; A Pande; J Wren; K M O'Brien; K C Kupfer; M H Wei; M Lerman; J D Minna; H R Garner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

6.  Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival.

Authors:  C G Willett; D I Smith; V Shridhar; M H Wang; R L Emanuel; K Patidar; S A Graham; F Zhang; V Hatch; D J Sugarbaker; M E Sunday
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 7.  Gene Therapy for Lung Cancer.

Authors:  Humberto Lara-Guerra; Jack A Roth
Journal:  Crit Rev Oncog       Date:  2016

8.  A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.

Authors:  D C Chung; A P Smith; D N Louis; F Graeme-Cook; A L Warshaw; A Arnold
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

9.  Direct transformation of rodent fibroblasts by jaagsiekte sheep retrovirus DNA.

Authors:  N Maeda; M Palmarini; C Murgia; H Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

10.  Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.

Authors:  Lin Han; Murali Ravoori; Guanglin Wu; Ryo Sakai; Shaoyu Yan; Sheela Singh; Kai Xu; Jack A Roth; Lin Ji; Vikas Kundra
Journal:  Mol Imaging       Date:  2013-10       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.